Sartorius Stedim Biotech SA (DIM) — Cash Flow-to-Debt Ratio
Sartorius Stedim Biotech SA (DIM) has a Cash Flow-to-Debt Ratio of 0.05x as of March 2026, meaning its operating cash flow of €182.60 Million could theoretically repay 0% of its total liabilities (€4.05 Billion) in one year. Explore long-term investment intensity of Sartorius Stedim Biotech SA to see how much of total assets are deployed in long-term investments.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Sartorius Stedim Biotech SA Cash Flow-to-Debt Ratio (2005–2025)
Historical debt coverage capacity for Sartorius Stedim Biotech SA across 21 annual periods. Also explore how large is Sartorius Stedim Biotech SA's balance sheet for the complete picture of this company's asset base.
Annual Cash Flow-to-Debt Ratio for Sartorius Stedim Biotech SA (2005–2025)
Year-by-year debt coverage analysis for Sartorius Stedim Biotech SA. For market capitalisation and broader financial context, see DIM market cap.
| Year | CF-to-Debt Ratio | Operating CF (EUR) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2025 | 0.14x | €538.60 Million | €3.89 Billion | ▼ -28.1% |
| 2024 | 0.19x | €815.10 Million | €4.23 Billion | ▲ +30.7% |
| 2023 | 0.15x | €746.40 Million | €5.07 Billion | ▼ -38.6% |
| 2022 | 0.24x | €612.30 Million | €2.55 Billion | ▼ -23.5% |
| 2021 | 0.31x | €695.97 Million | €2.22 Billion | ▲ +19.4% |
| 2020 | 0.26x | €416.88 Million | €1.59 Billion | ▼ -45.5% |
| 2019 | 0.48x | €310.13 Million | €642.79 Million | ▲ +11.8% |
| 2018 | 0.43x | €227.29 Million | €526.59 Million | ▲ +29.6% |
| 2017 | 0.33x | €174.69 Million | €524.45 Million | ▼ -8.1% |
| 2016 | 0.36x | €156.66 Million | €432.29 Million | ▲ +6.3% |
| 2015 | 0.34x | €142.79 Million | €418.92 Million | ▲ +12.8% |
| 2014 | 0.30x | €111.31 Million | €368.25 Million | ▲ +30.6% |
| 2013 | 0.23x | €90.11 Million | €389.39 Million | ▲ +69.9% |
| 2012 | 0.14x | €48.93 Million | €359.14 Million | ▼ -26.9% |
| 2011 | 0.19x | €60.59 Million | €325.04 Million | ▼ -25.4% |
| 2010 | 0.25x | €72.76 Million | €291.27 Million | ▼ -25.3% |
| 2009 | 0.33x | €91.86 Million | €274.66 Million | ▲ +98.8% |
| 2008 | 0.17x | €47.23 Million | €280.70 Million | ▲ +79.7% |
| 2007 | 0.09x | €26.02 Million | €277.96 Million | ▼ -62.3% |
| 2006 | 0.25x | €51.72 Million | €208.41 Million | ▲ +21.2% |
| 2005 | 0.20x | €43.85 Million | €214.18 Million | — |